Patient preferences for heart failure treatment: Utilities are valid measures of health-related quality of life in heart failure

Edward P. Havranek, Karen M. Mcgovern, Jennifer Weinberger, Anthony Brocato, Brian D. Lowes, William T. Abraham

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

Background: Current standards hold that cost-effectiveness analyses should incorporate measures of both quantity and quality of life, and that quality of life in this context is best measured by a utility. We sought to measure utility scores for patients with heart failure and to assess their validity as measures of health-related quality of life (HRQL). Methods and Results: We studied 50 patients with heart failure. We measured utilities with the time trade-off technique, exercise capacity with a 6-minute walk test, and HRQL with the Minnesota Living With Heart Failure questionnaire, the Medical Outcomes Study Short Form-36 (SF-36) questionnaire, and a visual analogue score. Validity was assessed by establishing correlation between utilities and these other measures. Mean utility score was 0.77 ± 0.28. There were significant (P < .05) curvilinear relationships between utility score and visual analogue score, the physical function summary scale of the SF-36, 6-minute walk distance, and the Living With Heart Failure score. Utility scores on retest at I week were unchanged in a subset of 12 patients. Utilities did not vary systematically with age, sex, or ethnicity. Conclusion: Utilities are valid measures of HRQL in patients with heart failure, and cost-effectiveness analyses of heart failure treatments incorporating utilities in the outcome measure can be meaningful.

Original languageEnglish (US)
Pages (from-to)85-91
Number of pages7
JournalJournal of Cardiac Failure
Volume5
Issue number2
DOIs
StatePublished - Jun 1999

Fingerprint

Patient Preference
Heart Failure
Quality of Life
Cost-Benefit Analysis
Therapeutics
Outcome Assessment (Health Care)
Exercise

Keywords

  • Cost effectiveness analyses
  • Heart failure
  • Quality of life

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Patient preferences for heart failure treatment : Utilities are valid measures of health-related quality of life in heart failure. / Havranek, Edward P.; Mcgovern, Karen M.; Weinberger, Jennifer; Brocato, Anthony; Lowes, Brian D.; Abraham, William T.

In: Journal of Cardiac Failure, Vol. 5, No. 2, 06.1999, p. 85-91.

Research output: Contribution to journalArticle

Havranek, Edward P. ; Mcgovern, Karen M. ; Weinberger, Jennifer ; Brocato, Anthony ; Lowes, Brian D. ; Abraham, William T. / Patient preferences for heart failure treatment : Utilities are valid measures of health-related quality of life in heart failure. In: Journal of Cardiac Failure. 1999 ; Vol. 5, No. 2. pp. 85-91.
@article{6b22c11b90624dd7ab9138676d4a8c81,
title = "Patient preferences for heart failure treatment: Utilities are valid measures of health-related quality of life in heart failure",
abstract = "Background: Current standards hold that cost-effectiveness analyses should incorporate measures of both quantity and quality of life, and that quality of life in this context is best measured by a utility. We sought to measure utility scores for patients with heart failure and to assess their validity as measures of health-related quality of life (HRQL). Methods and Results: We studied 50 patients with heart failure. We measured utilities with the time trade-off technique, exercise capacity with a 6-minute walk test, and HRQL with the Minnesota Living With Heart Failure questionnaire, the Medical Outcomes Study Short Form-36 (SF-36) questionnaire, and a visual analogue score. Validity was assessed by establishing correlation between utilities and these other measures. Mean utility score was 0.77 ± 0.28. There were significant (P < .05) curvilinear relationships between utility score and visual analogue score, the physical function summary scale of the SF-36, 6-minute walk distance, and the Living With Heart Failure score. Utility scores on retest at I week were unchanged in a subset of 12 patients. Utilities did not vary systematically with age, sex, or ethnicity. Conclusion: Utilities are valid measures of HRQL in patients with heart failure, and cost-effectiveness analyses of heart failure treatments incorporating utilities in the outcome measure can be meaningful.",
keywords = "Cost effectiveness analyses, Heart failure, Quality of life",
author = "Havranek, {Edward P.} and Mcgovern, {Karen M.} and Jennifer Weinberger and Anthony Brocato and Lowes, {Brian D.} and Abraham, {William T.}",
year = "1999",
month = "6",
doi = "10.1016/S1071-9164(99)90030-1",
language = "English (US)",
volume = "5",
pages = "85--91",
journal = "Journal of Cardiac Failure",
issn = "1071-9164",
publisher = "Churchill Livingstone",
number = "2",

}

TY - JOUR

T1 - Patient preferences for heart failure treatment

T2 - Utilities are valid measures of health-related quality of life in heart failure

AU - Havranek, Edward P.

AU - Mcgovern, Karen M.

AU - Weinberger, Jennifer

AU - Brocato, Anthony

AU - Lowes, Brian D.

AU - Abraham, William T.

PY - 1999/6

Y1 - 1999/6

N2 - Background: Current standards hold that cost-effectiveness analyses should incorporate measures of both quantity and quality of life, and that quality of life in this context is best measured by a utility. We sought to measure utility scores for patients with heart failure and to assess their validity as measures of health-related quality of life (HRQL). Methods and Results: We studied 50 patients with heart failure. We measured utilities with the time trade-off technique, exercise capacity with a 6-minute walk test, and HRQL with the Minnesota Living With Heart Failure questionnaire, the Medical Outcomes Study Short Form-36 (SF-36) questionnaire, and a visual analogue score. Validity was assessed by establishing correlation between utilities and these other measures. Mean utility score was 0.77 ± 0.28. There were significant (P < .05) curvilinear relationships between utility score and visual analogue score, the physical function summary scale of the SF-36, 6-minute walk distance, and the Living With Heart Failure score. Utility scores on retest at I week were unchanged in a subset of 12 patients. Utilities did not vary systematically with age, sex, or ethnicity. Conclusion: Utilities are valid measures of HRQL in patients with heart failure, and cost-effectiveness analyses of heart failure treatments incorporating utilities in the outcome measure can be meaningful.

AB - Background: Current standards hold that cost-effectiveness analyses should incorporate measures of both quantity and quality of life, and that quality of life in this context is best measured by a utility. We sought to measure utility scores for patients with heart failure and to assess their validity as measures of health-related quality of life (HRQL). Methods and Results: We studied 50 patients with heart failure. We measured utilities with the time trade-off technique, exercise capacity with a 6-minute walk test, and HRQL with the Minnesota Living With Heart Failure questionnaire, the Medical Outcomes Study Short Form-36 (SF-36) questionnaire, and a visual analogue score. Validity was assessed by establishing correlation between utilities and these other measures. Mean utility score was 0.77 ± 0.28. There were significant (P < .05) curvilinear relationships between utility score and visual analogue score, the physical function summary scale of the SF-36, 6-minute walk distance, and the Living With Heart Failure score. Utility scores on retest at I week were unchanged in a subset of 12 patients. Utilities did not vary systematically with age, sex, or ethnicity. Conclusion: Utilities are valid measures of HRQL in patients with heart failure, and cost-effectiveness analyses of heart failure treatments incorporating utilities in the outcome measure can be meaningful.

KW - Cost effectiveness analyses

KW - Heart failure

KW - Quality of life

UR - http://www.scopus.com/inward/record.url?scp=0033065385&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033065385&partnerID=8YFLogxK

U2 - 10.1016/S1071-9164(99)90030-1

DO - 10.1016/S1071-9164(99)90030-1

M3 - Article

C2 - 10404347

AN - SCOPUS:0033065385

VL - 5

SP - 85

EP - 91

JO - Journal of Cardiac Failure

JF - Journal of Cardiac Failure

SN - 1071-9164

IS - 2

ER -